The Kaplan-Meier plotter tool revealed that FASN was associated with poor RFS (P = 0.0093) outcome for ovarian cancer (Figure 8A) and poor OS (P = 1e-08), FP (P = 1.2e-06), and PPS (P = 0.019) prognosis for lung cancer (Figure 8B). Here, FASN is linked to ovarian carcinoma.